Jeschke U - Search Results

1

Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.

Heublein S, Mayr D, Egger M, Karsten U, Goletz S, Angele M, Gallwas J, Jeschke U, Ditsch N. Heublein S, et al. Among authors: jeschke u. J Exp Clin Cancer Res. 2015 May 19;34(1):50. doi: 10.1186/s13046-015-0152-7. J Exp Clin Cancer Res. 2015. PMID: 25986064 Free PMC article.

2

Expression of the Thomsen-Friedenreich (TF) antigen in the human placenta.

Richter DU, Jeschke U, Makovitzky J, Goletz S, Karsten U, Briese V, Friese K. Richter DU, et al. Among authors: jeschke u. Anticancer Res. 2000 Nov-Dec;20(6D):5129-33. Anticancer Res. 2000. PMID: 11326683

3

Expression of the Thomsen-Friedenreich antigen and of its putative carrier protein mucin 1 in the human placenta and in trophoblast cells in vitro.

Jeschke U, Richter DU, Hammer A, Briese V, Friese K, Karsten U. Jeschke U, et al. Histochem Cell Biol. 2002 Mar;117(3):219-26. doi: 10.1007/s00418-002-0383-5. Epub 2002 Feb 9. Histochem Cell Biol. 2002. PMID: 11914919

4

Glycodelin A and differentiation of first trimester trophoblast cells in vitro.

Jeschke U, Richter DU, Reimer T, Bergemann C, Briese V, Karsten U, Mylonas I, Kupka MS, Wiest I, Friese K. Jeschke U, et al. Arch Gynecol Obstet. 2005 Jul;272(2):151-9. doi: 10.1007/s00404-004-0682-2. Epub 2004 Nov 10. Arch Gynecol Obstet. 2005. PMID: 15549334

5

Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.

Schindlbeck C, Jeschke U, Schulze S, Karsten U, Janni W, Rack B, Sommer H, Friese K. Schindlbeck C, et al. Among authors: jeschke u. Histochem Cell Biol. 2005 Jun;123(6):631-7. doi: 10.1007/s00418-005-0781-6. Epub 2005 May 12. Histochem Cell Biol. 2005. PMID: 15889266

6

Stimulation of hCG protein and mRNA in first trimester villous cytotrophoblast cells in vitro by glycodelin A.

Jeschke U, Karsten U, Reimer T, Richter DU, Bergemann C, Briese V, Mylonas I, Friese K. Jeschke U, et al. J Perinat Med. 2005;33(3):212-8. doi: 10.1515/JPM.2005.039. J Perinat Med. 2005. PMID: 15914343

7

Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors.

Jeschke U, Bischof A, Speer R, Briese V, Richter DU, Bergemann C, Mylonas I, Shabani N, Friese K, Karsten U. Jeschke U, et al. Anticancer Res. 2005 May-Jun;25(3A):1581-9. Anticancer Res. 2005. PMID: 16033064 Free article.

8

Expression of the Thomsen-Friedenreich (TF) tumor antigen in human abort placentas.

Richter DU, Jeschke U, Bergemann C, Makovitzky J, Lüthen F, Karsten U, Briese V. Richter DU, et al. Among authors: jeschke u. Anticancer Res. 2005 May-Jun;25(3A):1675-8. Anticancer Res. 2005. PMID: 16033081 Free article.

9

Human chorionic gonadotropin (hCG) as inhibitior of E-selectin-mediated cell adhesion.

Stahn R, Goletz S, Stahn R, Wilmanowski R, Wang X, Briese V, Friese K, Jeschke U. Stahn R, et al. Among authors: jeschke u. Anticancer Res. 2005 May-Jun;25(3A):1811-6. Anticancer Res. 2005. PMID: 16033104 Free article.

10

Development and characterization of monoclonal antibodies for the immunohistochemical detection of glycodelin A in decidual, endometrial and gynaecological tumour tissues.

Jeschke U, Kuhn C, Mylonas I, Schulze S, Friese K, Mayr D, Speer R, Briese V, Richter DU, Haase M, Karsten U. Jeschke U, et al. Histopathology. 2006 Mar;48(4):394-406. doi: 10.1111/j.1365-2559.2006.02351.x. Histopathology. 2006. PMID: 16487361

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

459 results

Search Page

Filters